Developer docs
API playgroundTry for free, no card

Search company profiles

GraphiteRx

Full company profile

uuid0002rfn

Namestring
GraphiteRx
Legal namestring
GraphiteRx Inc.
Websiteurl
graphiterx.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

GraphiteRx is a U.S.-based healthcare commerce platform founded in 2018 and headquartered in Nashville, Tennessee, that operates a cloud-native, AI-powered B2B pharmaceutical commerce platform consolidating direct (non-wholesaler) drug procurement for hospitals, pharmacies, and clinics. The company addresses fragmented purchasing workflows, 340B compliance exposure, drug-shortage access, and supplier-side distribution costs that traditional three-wholesaler channels leave unsolved, particularly for smaller manufacturers and providers.

The platform is delivered through three integrated products: GraphiteOM, an all-in-one procurement and 340B compliance platform for health system pharmacies; ePortal, a pharma-specific e-commerce solution for manufacturers, distributors, and 503B outsourcers featuring DEA-certified CSOS, DSCSA traceability, automated license verification, and contract-specific pricing; and Marketplace Solutions, a turnkey 'marketplace in a box' that enables healthcare innovators and trade groups to launch co-branded B2B pharma marketplaces in weeks. The underlying technology includes an EDI hub processing standard transaction sets (832/850/855/856/810), AI-driven order management with anomaly detection, and an invoice-agent model that underwrites buyer credit risk and guarantees supplier payment regardless of buyer payment behavior.

GraphiteRx monetizes through marketplace and platform transaction fees on more than $500M in annual purchasing volume across 1,000+ provider organizations, managed-services revenue from credit-risk underwriting, and licensing/operational fees from white-label co-branded deployments, the most prominent being its Mark Cuban Cost Plus Drugs partnership that serves over 40 million patients annually. The company employs 11–50 staff, runs an enterprise field-sales motion targeting pharmacy and 340B leaders with first-year quotas near $1M ARR per rep, and supplements direct sales with GPO, trade-group, and healthcare-innovator partner channels.

Short descriptiontext

GraphiteRx operates a cloud-native, AI-powered B2B pharmaceutical commerce platform that consolidates non-wholesaler drug procurement, 340B compliance, and supplier e-commerce for hospitals, pharmacies, and manufacturers. It serves 1,000+ providers and powers white-label marketplaces including Cost Plus Drugs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNashville, United States
HQ citystring
Nashville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical procurement platform, 340B compliance software, B2B pharma marketplace, healthcare EDI integration, DSCSA traceability solutions
Industry5 codes
PRIMARYBPAMAGAD
B2B Marketplaces & Wholesale Platforms
Business & Public Services/Web, Mobile & Digital Platforms/E-commerce Marketplaces & Shopping Platforms
SECONDARYHLAFALAL
340B Program Administration & Contract Pharmacy Services
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
SECONDARYCRAOAHAK
Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops)
SECONDARYFSAGAJAC
Invoicing, Billing & Accounts Receivable Automation
Financial & Insurance/Financial Technology (Fintech)/B2B Fintech (SME Finance, Invoicing, Expense & Spend Management)
SECONDARYFSAGAIAC
B2B / Invoice-Based BNPL (Trade Credit at Checkout)
Financial & Insurance/Financial Technology (Fintech)/BNPL & Point-of-Sale Financing Platforms
NAICS code4 codes
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
  • Drugs and Druggists' Sundries Merchant Wholesalers4242
  • Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds524292
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Commerce Platform
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Marketplace Transaction Fees / Platform Fees
TypeTransaction Fee
Description

GraphiteRx operates a B2B pharmaceutical marketplace and earns revenue by facilitating transactions between buyers (hospitals, pharmacies, clinics) and suppliers (manufacturers, distributors). GraphiteRx acts as invoice agent, managing AR and credit risk, with pricing on open-market/WAC accounts with no markup or discount to supplier pricing.

graphiterx.com
2Supplier Payment Guarantee (B2B Marketplace)
TypeManaged Services
Description

GraphiteRx guarantees supplier payment for undisputed invoices regardless of customer payment timing. This credit risk underwriting function represents a revenue-generating service for suppliers, with GraphiteRx absorbing buyer credit risk in exchange for fees or spread.

graphiterx.com
3White-Label / Co-Branded Marketplace Licensing
TypeLicensing Royalties
Description

Partners (healthcare innovators, trade groups) pay for turnkey 'marketplace in a box' solutions — receiving a white-labeled, branded B2B pharma marketplace powered by GraphiteRx. Revenue generated from platform fees, transaction processing, and operational management services.

graphiterx.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Platform pricing is not publicly disclosed; all engagement is quote-based.
ModelOtherBilling cadenceAnnual
Notes

GraphiteRx operates on a B2B enterprise sales model with custom pricing. The platform facilitates transactions between buyers and suppliers. Suppliers list products at prices they define with no markup from GraphiteRx. GPO-affiliated pricing and class-of-trade pricing are supported.

graphiterx.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1GraphiteOM
Description

AI-powered all-in-one platform for health system pharmacies to manage 340B compliance and pharmacy procurement, including split-billing, audit readiness, and account validation.

graphiterx.com
+1 more record
Core offering1 text field

GraphiteRx operates a cloud-based B2B healthcare commerce platform that consolidates direct (non-wholesaler) pharmaceutical procurement onto a single AI-driven system. Its portfolio—GraphiteOM for provider procurement and 340B compliance, ePortal for supplier e-commerce with built-in CSOS/DSCSA/license verification, and turnkey Marketplace Solutions—unifies ordering, compliance, EDI integration, and supplier-payment guarantees. The platform powers white-label B2B pharma marketplaces, including the Cost Plus Drugs Marketplace for Businesses, serving over 1,000 hospitals, pharmacies, and clinics managing $500M+ in annual purchasing.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Over $500M in purchasing managed through the platform annually
+3 more records
Product overview1 text field

GraphiteRx operates as a healthcare commerce platform delivering AI-driven technology for pharmaceutical procurement, compliance, and marketplace solutions. The portfolio consists of three core integrated solutions: GraphiteOM (provider-facing procurement and 340B compliance platform), ePortal (supplier-facing pharma e-commerce solution), and Marketplace Solutions (turnkey B2B marketplace infrastructure). These products share a unified technology foundation with built-in compliance (340B, DSCSA, CSOS, license verification), EDI integration capabilities, and shared marketplace infrastructure, enabling seamless transactions across providers, suppliers, and marketplace operators including white-label partnerships like Cost Plus Drugs.

Product and service5 records
1GraphiteOM
CategoryHealthcare procurement and 340B compliance software
Description

All-in-one AI-powered platform for health system pharmacies, hospitals, and clinics to manage non-primary wholesaler purchasing, 340B compliance, split-billing, accumulation reporting, and audit readiness through a centralized procurement interface.

2ePortal (GraphiteRx eCommerce Solution)
CategoryPharmaceutical supplier e-commerce platform
Description

Pharma-specific e-commerce platform for manufacturers, distributors, and 503B outsourcing facilities, providing a branded online ordering experience with built-in compliance (CSOS, license verification), contract-specific pricing, and EDI/API integration to ERP or 3PL fulfillment systems.

3Marketplace Solutions
CategoryB2B pharmaceutical marketplace infrastructure
Description

Turnkey co-branded B2B pharmaceutical marketplace offering for healthcare innovators, trade groups, and partner organizations, bundling technology, compliance, payments, and operations into a 'marketplace in a box' that partners can white-label and launch in weeks.

4Graphite Marketplace
CategoryB2B pharmaceutical marketplace
Description

B2B pharmaceutical marketplace connecting hospitals, pharmacies, and clinics with manufacturers and authorized distributors for drug shortage products, specialty items, biosimilars, vaccines, and medical devices, with order-to-cash, compliance, and payment processing handled on platform.

5Cost Plus Drugs Marketplace for Businesses
CategoryWhite-label B2B pharmaceutical marketplace
Description

Co-branded B2B pharmaceutical marketplace powered by GraphiteRx for Mark Cuban Cost Plus Drugs, enabling healthcare providers to purchase lower-cost medications through a transparent, compliant ordering platform with GraphiteRx handling onboarding, EDI, fulfillment coordination, and payments.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2026-03-03
Description

GraphiteRx provides the technology infrastructure powering the Cost Plus Drugs Marketplace for Businesses. This includes customer onboarding, supplier management, EDI integrations, order processing, fulfillment coordination, payment processing, and customer support. Cost Plus Drugs focuses on its core mission of expanding access to affordable medications through transparency. The partnership was deepened in December 2025 and serves over 40 million patients annually.

2Group Purchasing Organizations (GPOs)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

GraphiteRx partners with GPOs and organizations that help providers manage spend. The partnership ensures hospitals, pharmacies, and clinics can reduce costs and access products through a unified marketplace. GPO-affiliated pricing and class-of-trade pricing are supported on the platform.

graphiterx.com
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

GraphiteRx partners with manufacturers, distributors, and 503B outsourcing facilities to enable direct-to-pharmacy distribution through the Graphite Marketplace. Suppliers gain access to over 1K hospitals, pharmacies, and clinics managing $500M+ in purchasing, with full control over catalog and pricing, and guaranteed payment.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Capital Rx is a next-generation PBM operating a transparent, technology-driven pharmacy benefit platform (Judi Health). Comparable to GraphiteRx in its mission to disrupt legacy pharma intermediaries with modern technology and transparent pricing.

2McKesson
TypeBroad incumbent
Description

McKesson is the largest U.S. pharmaceutical wholesaler and operates extensive 340B services (including Macro Helix/RxO). It is a broad incumbent that competes with GraphiteRx across primary and non-primary wholesale distribution, 340B administration, and digital procurement.

3BluePallet
TypeEmerging player
Description

BluePallet operates a B2B commerce and payments platform for the chemical and life sciences industry, with similar marketplace infrastructure (compliance, payments, EDI). Comparable to GraphiteRx's marketplace-in-a-box model applied to specialty inputs.

TypeBroad incumbent
Description

Cardinal Health is a top-three U.S. pharma distributor with a large hospital and ambulatory pharmacy footprint (including its OutcomesMTM and specialty businesses). Comparable to GraphiteRx across direct and non-primary wholesale distribution.

TypeDirect peer
Description

Cost Plus Drugs is GraphiteRx's flagship white-label partner and direct-to-consumer pharma disruptor. The Cost Plus Marketplace for Businesses is powered by GraphiteRx, so the two operate in tightly intertwined channels across DTC affordability and B2B procurement.

6RxBenefits
TypeEmerging player
Description

RxBenefits is a pharmacy benefits optimizer serving self-funded employers with PBM contracting, specialty drug procurement, and 340B advisory. Adjacent to GraphiteRx in its mission to lower drug costs through non-traditional procurement channels.

TypeDirect peer
Description

CaptureRx is a 340B contract pharmacy administrator and technology provider for hospitals and health systems. Direct overlap with GraphiteRx's 340B split-billing and contract pharmacy services for covered entities.

TypeBroad incumbent
Description

Cencora is the #2 U.S. pharma wholesaler with deep GPO relationships (Walgreens Boots Alliance Development, ClarusONE) and growing specialty/340B capabilities. Comparable to GraphiteRx in the wholesale and 340B channel-services arena, but at massive scale.

TypeDirect peer
Description

Macro Helix is a leading 340B program administration and split-billing platform serving covered entities. It is a direct competitor to GraphiteRx's GraphiteOM 340B compliance and accumulation-reporting functionality.

TypeDirect peer
Description

Sentry Data Systems provides 340B software, split-billing, and contract pharmacy administration to hospitals and FQHCs. Closely comparable to GraphiteOM's 340B compliance, audit-readiness, and account-validation workflows.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

GraphiteRx

Pharmaceutical Commerce Platformgraphiterx.com

GraphiteRx operates a cloud-native, AI-powered B2B pharmaceutical commerce platform that consolidates non-wholesaler drug procurement, 340B compliance, and supplier e-commerce for hospitals, pharmacies, and manufacturers. It serves 1,000+ providers and powers white-label marketplaces including Cost Plus Drugs.

What GraphiteRx does

GraphiteRx is a U.S.-based healthcare commerce platform founded in 2018 and headquartered in Nashville, Tennessee, that operates a cloud-native, AI-powered B2B pharmaceutical commerce platform consolidating direct (non-wholesaler) drug procurement for hospitals, pharmacies, and clinics. The company addresses fragmented purchasing workflows, 340B compliance exposure, drug-shortage access, and supplier-side distribution costs that traditional three-wholesaler channels leave unsolved, particularly for smaller manufacturers and providers.

The platform is delivered through three integrated products: GraphiteOM, an all-in-one procurement and 340B compliance platform for health system pharmacies; ePortal, a pharma-specific e-commerce solution for manufacturers, distributors, and 503B outsourcers featuring DEA-certified CSOS, DSCSA traceability, automated license verification, and contract-specific pricing; and Marketplace Solutions, a turnkey 'marketplace in a box' that enables healthcare innovators and trade groups to launch co-branded B2B pharma marketplaces in weeks. The underlying technology includes an EDI hub processing standard transaction sets (832/850/855/856/810), AI-driven order management with anomaly detection, and an invoice-agent model that underwrites buyer credit risk and guarantees supplier payment regardless of buyer payment behavior.

GraphiteRx monetizes through marketplace and platform transaction fees on more than $500M in annual purchasing volume across 1,000+ provider organizations, managed-services revenue from credit-risk underwriting, and licensing/operational fees from white-label co-branded deployments, the most prominent being its Mark Cuban Cost Plus Drugs partnership that serves over 40 million patients annually. The company employs 11–50 staff, runs an enterprise field-sales motion targeting pharmacy and 340B leaders with first-year quotas near $1M ARR per rep, and supplements direct sales with GPO, trade-group, and healthcare-innovator partner channels.

GraphiteRx firmographics

Firmographics
Name
GraphiteRx
Legal name
GraphiteRx Inc.
Website
https://graphiterx.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
GraphiteRx operates a cloud-native, AI-powered B2B pharmaceutical commerce platform that consolidates non-wholesaler drug procurement, 340B compliance, and supplier e-commerce for hospitals, pharmacies, and manufacturers. It serves 1,000+ providers and powers white-label marketplaces including Cost Plus Drugs.
Ownership category
akta.pro rank

GraphiteRx industry classification

Industry
Product category
Pharmaceutical Commerce Platform
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (4242), Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYBPAMAGAD
B2B Marketplaces & Wholesale Platforms
Business & Public Services/Web, Mobile & Digital Platforms/E-commerce Marketplaces & Shopping Platforms
SECONDARYHLAFALAL
340B Program Administration & Contract Pharmacy Services
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
SECONDARYCRAOAHAK
Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops)
SECONDARYFSAGAJAC
Invoicing, Billing & Accounts Receivable Automation
Financial & Insurance/Financial Technology (Fintech)/B2B Fintech (SME Finance, Invoicing, Expense & Spend Management)
SECONDARYFSAGAIAC
B2B / Invoice-Based BNPL (Trade Credit at Checkout)
Financial & Insurance/Financial Technology (Fintech)/BNPL & Point-of-Sale Financing Platforms

Keywords

  • Pharmaceutical procurement platform
  • 340B compliance software
  • B2B pharma marketplace
  • Healthcare EDI integration
  • DSCSA traceability solutions

Where GraphiteRx is headquartered

Location

Headquarters

HQ city
Nashville
HQ country
United States
HQ region
North America

Offices1 record

Markets served

GraphiteRx business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Marketplace Transaction Fees / Platform Fees: GraphiteRx operates a B2B pharmaceutical marketplace and earns revenue by facilitating transactions between buyers (hospitals, pharmacies, clinics) and suppliers (manufacturers, distributors). GraphiteRx acts as invoice agent, managing AR and credit risk, with pricing on open-market/WAC accounts with no markup or discount to supplier pricing.
  2. Supplier Payment Guarantee (B2B Marketplace): GraphiteRx guarantees supplier payment for undisputed invoices regardless of customer payment timing. This credit risk underwriting function represents a revenue-generating service for suppliers, with GraphiteRx absorbing buyer credit risk in exchange for fees or spread.
  3. White-Label / Co-Branded Marketplace Licensing: Partners (healthcare innovators, trade groups) pay for turnkey 'marketplace in a box' solutions — receiving a white-labeled, branded B2B pharma marketplace powered by GraphiteRx. Revenue generated from platform fees, transaction processing, and operational management services.

Pricing tiers

ModelBillingPrice
OtherAnnualPlatform pricing is not publicly disclosed; all engagement is quote-based.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

GraphiteRx product offering

Product offering

Core offering

GraphiteRx operates a cloud-based B2B healthcare commerce platform that consolidates direct (non-wholesaler) pharmaceutical procurement onto a single AI-driven system. Its portfolio—GraphiteOM for provider procurement and 340B compliance, ePortal for supplier e-commerce with built-in CSOS/DSCSA/license verification, and turnkey Marketplace Solutions—unifies ordering, compliance, EDI integration, and supplier-payment guarantees. The platform powers white-label B2B pharma marketplaces, including the Cost Plus Drugs Marketplace for Businesses, serving over 1,000 hospitals, pharmacies, and clinics managing $500M+ in annual purchasing.

Product overview

GraphiteRx operates as a healthcare commerce platform delivering AI-driven technology for pharmaceutical procurement, compliance, and marketplace solutions. The portfolio consists of three core integrated solutions: GraphiteOM (provider-facing procurement and 340B compliance platform), ePortal (supplier-facing pharma e-commerce solution), and Marketplace Solutions (turnkey B2B marketplace infrastructure). These products share a unified technology foundation with built-in compliance (340B, DSCSA, CSOS, license verification), EDI integration capabilities, and shared marketplace infrastructure, enabling seamless transactions across providers, suppliers, and marketplace operators including white-label partnerships like Cost Plus Drugs.

Differentiator

Problem solved

Functional benefit

Brands

  • GraphiteOM: AI-powered all-in-one platform for health system pharmacies to manage 340B compliance and pharmacy procurement, including split-billing, audit readiness, and account validation.
  • ePortal

Products and services

  • GraphiteOM All-in-one AI-powered platform for health system pharmacies, hospitals, and clinics to manage non-primary wholesaler purchasing, 340B compliance, split-billing, accumulation reporting, and audit readiness through a centralized procurement interface.
  • ePortal (GraphiteRx eCommerce Solution) Pharma-specific e-commerce platform for manufacturers, distributors, and 503B outsourcing facilities, providing a branded online ordering experience with built-in compliance (CSOS, license verification), contract-specific pricing, and EDI/API integration to ERP or 3PL fulfillment systems.
  • Marketplace Solutions Turnkey co-branded B2B pharmaceutical marketplace offering for healthcare innovators, trade groups, and partner organizations, bundling technology, compliance, payments, and operations into a 'marketplace in a box' that partners can white-label and launch in weeks.
  • Graphite Marketplace B2B pharmaceutical marketplace connecting hospitals, pharmacies, and clinics with manufacturers and authorized distributors for drug shortage products, specialty items, biosimilars, vaccines, and medical devices, with order-to-cash, compliance, and payment processing handled on platform.
  • Cost Plus Drugs Marketplace for Businesses Co-branded B2B pharmaceutical marketplace powered by GraphiteRx for Mark Cuban Cost Plus Drugs, enabling healthcare providers to purchase lower-cost medications through a transparent, compliant ordering platform with GraphiteRx handling onboarding, EDI, fulfillment coordination, and payments.

Quantifiable outcome

  • Over $500M in purchasing managed through the platform annually
  • +3 more outcomes

Companies that use GraphiteRx

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

GraphiteRx technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability3 records

Feature8 records

GraphiteRx partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Mark Cuban Cost Plus DrugscoreOEM/ Whitelabel/ Licensing Partner · 3 March 2026GraphiteRx provides the technology infrastructure powering the Cost Plus Drugs Marketplace for Businesses. This includes customer onboarding, supplier management, EDI integrations, order processing, fulfillment coordination, payment processing, and customer support. Cost Plus Drugs focuses on its core mission of expanding access to affordable medications through transparency. The partnership was deepened in December 2025 and serves over 40 million patients annually.
  • Group Purchasing Organizations (GPOs)coreChannel Partner/ Reseller/ DistributorGraphiteRx partners with GPOs and organizations that help providers manage spend. The partnership ensures hospitals, pharmacies, and clinics can reduce costs and access products through a unified marketplace. GPO-affiliated pricing and class-of-trade pricing are supported on the platform.
  • Pharmaceutical Manufacturers and DistributorscoreChannel Partner/ Reseller/ DistributorGraphiteRx partners with manufacturers, distributors, and 503B outsourcing facilities to enable direct-to-pharmacy distribution through the Graphite Marketplace. Suppliers gain access to over 1K hospitals, pharmacies, and clinics managing $500M+ in purchasing, with full control over catalog and pricing, and guaranteed payment.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

GraphiteRx competitors and assessment

Company assessment

Emerging players

  • Capital Rx: Capital Rx is a next-generation PBM operating a transparent, technology-driven pharmacy benefit platform (Judi Health). Comparable to GraphiteRx in its mission to disrupt legacy pharma intermediaries with modern technology and transparent pricing.
  • BluePallet: BluePallet operates a B2B commerce and payments platform for the chemical and life sciences industry, with similar marketplace infrastructure (compliance, payments, EDI). Comparable to GraphiteRx's marketplace-in-a-box model applied to specialty inputs.
  • RxBenefits: RxBenefits is a pharmacy benefits optimizer serving self-funded employers with PBM contracting, specialty drug procurement, and 340B advisory. Adjacent to GraphiteRx in its mission to lower drug costs through non-traditional procurement channels.

Broad incumbents

  • McKesson: McKesson is the largest U.S. pharmaceutical wholesaler and operates extensive 340B services (including Macro Helix/RxO). It is a broad incumbent that competes with GraphiteRx across primary and non-primary wholesale distribution, 340B administration, and digital procurement.
  • Cardinal Health: Cardinal Health is a top-three U.S. pharma distributor with a large hospital and ambulatory pharmacy footprint (including its OutcomesMTM and specialty businesses). Comparable to GraphiteRx across direct and non-primary wholesale distribution.
  • Cencora (AmerisourceBergen): Cencora is the #2 U.S. pharma wholesaler with deep GPO relationships (Walgreens Boots Alliance Development, ClarusONE) and growing specialty/340B capabilities. Comparable to GraphiteRx in the wholesale and 340B channel-services arena, but at massive scale.

Direct peers

  • Mark Cuban Cost Plus Drug Company: Cost Plus Drugs is GraphiteRx's flagship white-label partner and direct-to-consumer pharma disruptor. The Cost Plus Marketplace for Businesses is powered by GraphiteRx, so the two operate in tightly intertwined channels across DTC affordability and B2B procurement.
  • CaptureRx: CaptureRx is a 340B contract pharmacy administrator and technology provider for hospitals and health systems. Direct overlap with GraphiteRx's 340B split-billing and contract pharmacy services for covered entities.
  • Macro Helix (McKesson): Macro Helix is a leading 340B program administration and split-billing platform serving covered entities. It is a direct competitor to GraphiteRx's GraphiteOM 340B compliance and accumulation-reporting functionality.
  • Sentry Data Systems (Cencora/World Courier): Sentry Data Systems provides 340B software, split-billing, and contract pharmacy administration to hospitals and FQHCs. Closely comparable to GraphiteOM's 340B compliance, audit-readiness, and account-validation workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

GraphiteRx social profiles

Digital presence

GraphiteRx compliance and trust

Trust signal

Compliance1 record

GraphiteRx financial estimates

Financial estimate

Revenue estimate

Valuation estimate

GraphiteRx leadership team

Management profile

Number of profiles

Profiles3 records

GraphiteRx funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

GraphiteRx M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GraphiteRx

What does GraphiteRx do?

GraphiteRx operates a cloud-based B2B healthcare commerce platform that consolidates direct (non-wholesaler) pharmaceutical procurement onto a single AI-driven system. Its portfolio—GraphiteOM for provider procurement and 340B compliance, ePortal for supplier e-commerce with built-in CSOS/DSCSA/license verification, and turnkey Marketplace Solutions—unifies ordering, compliance, EDI integration, and supplier-payment guarantees. The platform powers white-label B2B pharma marketplaces, including the Cost Plus Drugs Marketplace for Businesses, serving over 1,000 hospitals, pharmacies, and clinics managing $500M+ in annual purchasing.

Is GraphiteRx a public or private company?

GraphiteRx is a private company. It is classified as venture growth investor backed and is currently operating.

When was GraphiteRx founded?

GraphiteRx was founded in 2018. It employs 11 to 50 people.

Where is GraphiteRx based?

GraphiteRx is headquartered in Nashville, United States, in the North America region.

How does GraphiteRx make money?

Three revenue lines are on record. Marketplace Transaction Fees / Platform Fees are the primary driver. The others are supplier Payment Guarantee (B2B Marketplace) and white-Label / Co-Branded Marketplace Licensing.

Who are GraphiteRx's main competitors?

Emerging players on record are Capital Rx, BluePallet and RxBenefits. Broad incumbents are McKesson, Cardinal Health and Cencora (AmerisourceBergen). Direct peers are Mark Cuban Cost Plus Drug Company, CaptureRx, Macro Helix (McKesson) and Sentry Data Systems (Cencora/World Courier).

Does GraphiteRx have an API?

No public API is recorded for GraphiteRx.

What industry is GraphiteRx in?

GraphiteRx's product category is Pharmaceutical Commerce Platform. Its primary akta.pro industry code is BPAMAGAD, B2B Marketplaces & Wholesale Platforms, with a secondary code of HLAFALAL, 340B Program Administration & Contract Pharmacy Services. Its NAICS code is 42421 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireBluesight Partners with GraphiteRx and Mark Cuban Cost Plus Drugs to Expand Access to Cost-Saving Medication SourcesBluesight, a hospital intelligence solutions provider, announced a strategic partnership with GraphiteRx to integrate Mark Cuban Cost Plus Drugs pricing into its CostCheck and ShortageCheck procurement tools. The collaboration gives hospital pharmacies access to alternative medication suppliers alongside traditional wholesalers, addressing two critical challenges: rising drug costs and persistent drug shortages. According to Bluesight's data, 77% of hospital pharmacies identified reducing drug spend as a top priority while 75% cited drug shortages as their most pressing operational challenge.PharmiWeb.comGraphiteRx and Mark Cuban Cost Plus Drugs Deepen Partnership to Advance Availability of Lower-Cost MedicationsGraphiteRx and Mark Cuban Cost Plus Drugs announced an expanded partnership to improve the availability of affordable medications for healthcare providers, supporting cost savings and supply reliability. The collaboration enhances the CPM platform which offers significant medication discounts and operational visibility. The partnership aims to further reduce costs and improve access to key drugs over the long term.Business InsiderI left the Bay Area to launch my startup in Nashville — and it was the best decision I could have made for my business and familyThe author left the Bay Area to open his startup GraphiteRx's office in Nashville in September 2019, citing healthcare talent and a growing tech ecosystem. He relocated his family, bought a larger home for the same price, and reduced his commute to 10-15 minutes. He expects Nashville to be the place where tech is going.